<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We used a rat model of <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> to evaluate whether <z:hpo ids='HP_0000822'>hypertension</z:hpo> increases the incidence of <z:mp ids='MP_0001914'>hemorrhage</z:mp> after fibrinolysis with tissue plasminogen activator (tPA) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In this model, a microclot suspension was injected into the middle cerebral artery territory to induce focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Reperfusion was induced in spontaneously hypertensive rats (SHR) by administering tPA (10 mg/kg) intravenously at 2 hours or 6 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of thromboembolic focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In untreated control rats, saline was administered at 2 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Hemorrhagic transformation was observed only in rats that received tPA at 6 hours (6 of 8 rats [75%]) </plain></SENT>
<SENT sid="5" pm="."><plain>Reduction of mean arterial blood pressure from 122+/-3 to 99+/-2 mm Hg with hydralazine, given to SHR for 1 week before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, significantly decreased the incidence of <z:mp ids='MP_0001914'>hemorrhage</z:mp> in 2 of 11 rats (18%) </plain></SENT>
<SENT sid="6" pm="."><plain>tPA reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes, but cotreatment with hydralazine did not result in further protection </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: This study demonstrates that in this rat thromboembolic model of <z:hpo ids='HP_0001297'>stroke</z:hpo>, tPA-induced <z:mp ids='MP_0001914'>hemorrhage</z:mp> is dependent on blood pressure and that pharmacological reduction of <z:hpo ids='HP_0000822'>hypertension</z:hpo> during fibrinolysis can reduce the risk of hemorrhagic transformation </plain></SENT>
</text></document>